05 May 2007 Viragen Shifts Development Focus for Anti-Cancer Products
04 May 2007 Herceptin approved in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2 and hormone receptor-co-positive metastatic breast cancer
04 May 2007 Data Presented at the American Academy on Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabry(R) in Patients with Multiple Sclerosis
03 May 2007 Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
03 May 2007 ThromboGenics Announces Progress With its Pre-Clinical and Clinical Programs
03 May 2007 Y's Therapeutics Initiates Phase II Trial With YSPSL in Liver Transplant Patients for Prevention of Ischemic Reperfusion (I/R) Injury
02 May 2007 Progenics Announces Positive Results in Clinical Trial of Novel HIV Therapy
02 May 2007 Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
01 May 2007 Dr. Reddy's launches Reditux(TM) Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma
01 May 2007 Final Vectibix(TM) Positive Pivotal Phase 3 Trial Results In Metastatic Colorectal Cancer Patients Published
28 Apr 2007 Abbott's HUMIRA(R) (adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
28 Apr 2007 CHMP Adopts Positive Opinion For Alexion's Soliris(TM) In Europe
27 Apr 2007 PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in Intravenous Steroid-Refractory Ulcerative Colitis
27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
25 Apr 2007 Y's Therapeutics Completes Enrollment of Phase II Trial in the U.S. With YSPSL for Prevention of Delayed Graft Function in Renal Transplantation
24 Apr 2007 Micromet Achieves Milestone in BiTE(R) Research Collaboration with MedImmune
24 Apr 2007 KaloBios Licenses Humaneering(TM) Technology to Major Pharmaceutical Company
20 Apr 2007 MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule
19 Apr 2007 Anti-Cancer Agent Avastin(R), Approved in Japan
19 Apr 2007 Viventia Biotech generates novel human anti-cancer antibody, VB1-050, and identifies its novel target
18 Apr 2007 Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
18 Apr 2007 Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
18 Apr 2007 Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
17 Apr 2007 YM BioSciences' Partner Daiichi Sankyo Receives Clearance for Initial Clinical Trial in Japan
17 Apr 2007 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up